|
Originally published In Press as doi:10.1074/jbc.M000600200 on June 23, 2000
J. Biol. Chem., Vol. 275, Issue 41, 31601-31608, October 13, 2000
Acute Regulation of Na+/H+ Exchanger NHE3
by Parathyroid Hormone via NHE3 Phosphorylation and
Dynamin-dependent Endocytosis*
Roberto
Collazo ,
Lingzhi
Fan,
Ming Chang
Hu,
Hui
Zhao,
Michael R.
Wiederkehr, and
Orson W.
Moe§
From the Medical Service, Department of Veterans Affairs Medical
Center and Department of Internal Medicine, University of Texas
Southwestern Medical Center, Dallas, Texas 75235
Received for publication, January 27, 2000, and in revised form, June 23, 2000
 |
ABSTRACT |
Parathyroid hormone (PTH) is a potent inhibitor
of mammalian renal proximal tubule Na+
transport via its action on the apical membrane
Na+/H+ exchanger NHE3. In the opossum kidney
cell line, inhibition of NHE3 activity was detected from 5 to 45 min after PTH addition. Increase in NHE3 phosphorylation on multiple
serines was evident after 5 min of PTH, but decrease in surface NHE3
antigen was not detectable until after 30 min of PTH. The decrease in
surface NHE3 antigen was due to increased NHE3 endocytosis. When
endocytic trafficking was arrested with a dominant negative dynamin
mutant (K44A), the early inhibition (5 min) of NHE3 activity by PTH was not affected, whereas the late inhibition (30 min) and decreased surface NHE3 antigen induced by PTH were abrogated. We conclude that
PTH acutely inhibits NHE3 activity in a biphasic fashion by NHE3
phosphorylation followed by dynamin-dependent endocytosis.
 |
INTRODUCTION |
The calcitropic effect of
PTH1 is effected by altering
calcium flux between the plasma and the skeleton, intestine, and kidney in a concerted fashion. In the mammalian kidney, PTH is the principal anti-calciuric hormone exerting its action on the proximal tubule, thick ascending limb, and the distal convoluted tubule (1-4). In the
renal proximal tubule, PTH is a potent inhibitor of NaHCO3 absorption (5-11) that results in increased delivery to the distal nephron where NaHCO3 acts as an important stimulus for
active transcellular Ca2+ absorption (12-14). In the
mammalian proximal tubule, two-thirds of the transcellular
NaHCO3 absorption is mediated by apical membrane Na+/H+ exchange (15) which is coded by the NHE3
isoform (16-18), a member of the multigene family of mammalian
Na+/H+ exchangers (19-21). Inhibition of
proximal tubule HCO3 absorption by PTH (5-11) has been
shown to be mediated by decreased Na+/H+
exchange activity using suspended tubules (22), isolated in vitro perfused tubules (23), in vivo perfused tubule
(24), apical membrane vesicles (25, 26), cultured renal cells (27-34), and non-epithelial cells transfected with the PTH receptor and NHE3 gene (35-36).
Acute inhibition of NHE3 can potentially be mediated by multiple
mechanisms including NHE3 phosphorylation, binding to regulatory factors, and alteration of surface NHE3 protein abundance (37, 38). In
cultured cells, acute regulation of NHE3 has been shown to be
accompanied by NHE3 phosphorylation (39-45), and the functional role
of phosphorylation has been demonstrated for PKA and PKC (40, 42, 44).
The signal transduction cascade mediating the effect of PTH on NHE3 is
complex, likely involving multiple pathways, but at least part of the
effect of PTH on NHE3 is PKA-dependent (29-32, 35, 36). In
the intact animal, acute infusion of PTH increases NHE3 phosphorylation
as assayed by mobility retardation (26) which lends additional support
for the importance of NHE3 phosphorylation in its regulation. This
paper further characterizes the time course and pattern of NHE3
phosphorylation in OK cells in response to PTH.
It is presently unclear how phosphorylation of NHE3 alters its
transport activity. One mechanism that has been shown to alter acutely
NHE3 transport activity is the change in cell surface protein
abundance. This has been demonstrated in cultured cells (46-48) as
well as in intact kidney (26, 49-53). Two studies have shown that
acute infusion of PTH leads to a decrease in proximal tubule apical
membrane NHE3 using immunohistochemistry (53) and membrane vesicles
(26). It is unclear whether this acute decrement in apical membrane
NHE3 is due to decreased exocytic insertion, endocytotic
internalization, or both. Studies in rat kidney suggest that acute
changes in apical membrane NHE3 abundance is
microtubule-dependent (26) and is partially mediated by the cytochrome P450 system (50). There is evidence in cell culture that
NHE3 is recycled via phosphatidylinositol
3-kinase-dependent mechanisms (46, 47) and is internalized
through clathrin-mediated pathway in fibroblasts (54). Full expression
of NHE3 activity is dependent on the integrity of the cytoskeleton, and
NHE3 co-sediments with the actin cytoskeleton (55). This study will
define some of the mechanisms by which PTH acutely decreases surface
NHE3 in a renal epithelial cell.
 |
MATERIALS AND METHODS |
Cell Culture and Transfection of Cells--
OK cells were
passaged in high glucose Dulbecco's modified Eagle's medium,
supplemented with Na+ pyruvate (1 mM), fetal
bovine serum (10%, v/v), penicillin (100 units/ml), and streptomycin
(100 mg/ml) and were rendered quiescent post-confluence by serum
removal for 48 h prior to experimentation. To examine the role of
dynamin on regulation of NHE3 activity by PTH, transient transfections
of OK cells were performed with the following plasmids:
carboxyl-terminal c-Myc-tagged opossum NHE3, hemagglutinin-tagged wild
type (dynWT), and dominant negative GTP-binding defective
dynamin (dynK44A) using LipofectAMINE (dynamin plasmids
were kindly provided by Dr. Sandra Schmid, La Jolla, CA) (56).
Transfection efficiency was monitored by co-transfection with
-galactosidase and staining cells with
5-bromo-4-chloro-3-indolyl -D-galactopyranoside (X-gal) as well as staining with anti-hemagglutinin antibody. For experiments examining the effect of dynamin on the regulation of NHE3 by PTH, only
cells with transfection efficiency greater than 80% were used.
NHE3 Activity Assay--
NHE3 activity was measured
fluorimetrically with the pH-sensitive dye BCECF as
Na+-dependent pHi recovery
(dpHi/dt) after an acid load using the
K+/H+ ionophore nigericin as described
previously (57). BCECF calibration curves to convert fluorescence to
pHi values were obtained by nigericin permeation at varying
levels of extracellular pH. PTH addition had no effect on the buffer
capacity, trough pH during Na+ addition, or
nigericin calibration curves (data not shown). For paired measurements,
a base-line dpHi/dt was obtained after
NH4+/NH3 prepulse/withdrawal
(20 mM NH4Cl) followed by Na+
addition (58). PTH or vehicle was then added for the specified time,
and a second dpHi/dt was obtained with
NH4+/NH3 prepulse/withdrawal
and Na+ addition.
In Vivo NHE3 Phosphorylation--
After incubation in
phosphate-free Dulbecco's modified Eagle's medium (60 min), OK cells
were pulsed with phosphate-free medium containing
[32P]orthophosphate (300 mCi/ml) for 120 min. PTH
(10 7 M) or vehicle was added, and
the cells were washed, lysed with RIPA buffer (in mM, 300 NaCl, 80 NaF, 50 Tris-HCl, pH 7.4, 5 EDTA, 10 EGTA, 25 Na+
pyrophosphate, 1 activated Na+ orthovanadate, 50 -glycerophosphate, 0.5 dithiothreitol; Triton X-100 1% (v/v),
deoxycholate 0.5% (w/v), SDS 0.1% (w/v); in mg/ml, 100 phenylmethylsulfonyl fluoride, 4 leupeptin, 4 aprotinin, 10 pepstatin),
and lysate was centrifuged (109,000 × g at
rmax, 50,000 rpm, 25 min, 2 °C, Beckman
TLX/TLA 100.3 rotor, Fullerton, CA). The supernatant was retrieved and
mixed with an equal amount of water, and NHE3 was immunoprecipitated
(antiserum:lysate, 5:1000 dilution, v/v) with a polyclonal antisera
(number 5683, directed against a chimeric protein consisting of
maltose-binding protein and opossum NHE3 amino acids 484-839).
Immunoblot was performed with antiserum 5683 (1:1000) and goat
anti-rabbit antibody (1:5000) using enhanced chemiluminescence (ECL).
The 32P content of NHE3 was visualized by autoradiography
on the same filters after ECL decay. Both signals were quantified by
densitometry, and changes in phosphorylation were normalized to the
antigenic signal. For tryptic phosphopeptide and phosphoamino acid
analysis, the in vivo 32P-phosphorylated,
immunoprecipitated NHE3 was excised and extracted (100 mM
acetic acid containing 0.5% polyvinylpyrrolidone at 37 °C for 30 min) from the nitrocellulose filter and digested with 15 mg
L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin in 0.05 M NH4HCO3 at
37 °C. The released phosphopeptides were washed with water,
lyophilized repeatedly, and resuspended in electrophoresis buffer (per
liter, 25 ml of 88% (w/v) formic acid, 78 ml of glacial acetic acid,
897 ml of deionized water, pH 1.95) and fractionated with sequential
electrophoresis (1.0 kV for 40 min, Hunter Electrophoresis Unit HTLE
7000, CBS Scientific Co., Del Mar, CA) and ascending chromatography
(375:250:75:300 (v/v) n-butyl alcohol, pyridine,
glacial acetic acid, deionized water) on cellulose TLC plates as
described previously (42). Phosphopeptide spots were identified by
autoradiography. For phosphoamino acid analysis, purified
phosphoproteins were hydrolyzed by boiling in 6 M HCl, and
32P-labeled amino acids were electrophoretically resolved
on a Hunter Unit (first dimension, 2.2% formic acid, 7.8% acetic
acid, pH 1.9; second dimension, 5% acetic acid, 0.5% pyridine, pH
3.5) along with the cold Ser(P), Thr(P), and Tyr(P) standards.
Phosphoamino acids were identified by autoradiography and aligned with
ninhydrin-stained standards.
Assay of NHE3 Surface Antigen and NHE3 Endocytosis--
To
measure surface NHE3, OK cells were treated with either agonist or
vehicle and then surface-labeled with biotin using a modification of
the method of Gottardi et al. (59). After rinsing (PBS-Ca2+/Mg2+ in mM, 150 NaCl, 10 Na2HPO4, pH 7.40, 0.1 CaCl2, 1 MgCl2), cells were treated with 2 mg/ml of NHS-SS-biotin
(Pierce) in buffer (in mM, 150 NaCl, 10 triethanolamine, pH
7.4, 2 CaCl2), quenched (PBS-Ca2+/Mg2+, with 100 mM
glycine), and lysed in biotin-RIPA (150 NaCl, 50 Tris-HCl, pH 7.4, 5 EDTA, 1% (v/v) Triton X-100, 0.5% (w/v) deoxycholate, 0.1% (w/v)
SDS). Lysates were clarified by ultracentrifugation (109,000 × g at rmax, 50,000 rpm, 25 min,
2 °C, Beckman TLX/TLA 100.3 rotor, Fullerton, CA), and protein
content was quantified by the method Bradford. Equal amounts of cell
lysate were equilibrated with streptavidin-agarose (Pierce) at 4 °C.
Beads were washed sequentially with solutions A (in mM, 50 Tris-HCl, pH 7.4, 100 NaCl, 5 EDTA), B (in mM, 50 Tris-HCl,
pH 7.4, 500 NaCl), and C (50 mM Tris-HCl, pH 7.4), and
biotinylated proteins were released by incubation in 100 mM
dithiothreitol, reconstituted in Laemmli's buffer, and subjected to
SDS-polyacrylamide gel electrophoresis and labeled with either
anti-NHE3 antiserum 5683 or for experiments with exogenous c-Myc-tagged
NHE3 a monoclonal anti-c-Mxc was used (Invitrogen). Endocytosis was
measured by a protocol adapted and modified from the stage-specific
Mes/Na+-resistant and avidin protection endocytosis assays
originally described by Carter and co-workers (60). OK cells were
surface-labeled with NHS-SS-biotin and quenched exactly as described
above. Cells were then warmed to 37 °C in the presence of
10 7 M PTH or vehicle to allow
endocytosis to occur over 30-40 min. Surface biotin was then saturated
with avidin (50 mg/ml PBS) and washed with biocytin (50 mg/ml PBS), or
alternatively, surface biotin were cleaved with the small
cell-impermeant reducing agent TCEP (100 mM in 50 mM Tris, pH 7.4). The freshly endocytosed biotinylated proteins were protected from either avidin saturation or TCEP cleavage.
Cells were then solubilized in RIPA, and biotinylated proteins were
retrieved and assayed for NHE3 as described above. Avidin-protected
fraction measures early and late endocytosis because avidin cannot
enter the constricted necks of clathrin-coated pits. TCEP-protected
fraction measures late endocytosis because complete excommunication
from the exterior is required to prevent TCEP access.
 |
RESULTS |
PTH Inhibits NHE3 Activity--
PTH inhibited NHE3 activity
measured as Na+-dependent pHi recovery
in OK cells as shown by the representative tracing (Fig.
1A). Dose and time dependence
of inhibition of NHE3 activity by PTH are summarized in Fig. 1,
B and C. PTH inhibits NHE3 activity as early as 5 min and over the concentration from 10 8 to
10 5 M. These findings are very
similar to previously reported results (29, 31, 32). We next examined
the effect of PTH on NHE3 phosphorylation.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of PTH on NHE3 activity in OK
cells. A, representative tracing of NHE3 activity
assayed fluorimetrically (BCECF) as
Na+-dependent intracellular pH recovery
(dpHi/dt) after acid load. PTH
(10 7 M) was added for 20 min.
B, summary of data for time response of NHE3 activity to
10 7 M PTH. Symbols and
bars depict mean ± S.E. Asterisk indicates
significant difference from control (p < 0.05, ANOVA).
Control (n = number of experiments) n = 14; 5 min, n = 6; 15 min, n = 9; 30 min
n = 12. C, summary of data for dose response
of NHE3 to 30 min of PTH. Symbols and bars depict
mean ± S.E. Asterisk indicates significant difference
from control (p < 0.05, ANOVA). Control
(n = number of experiments), n = 14;
10 9 M, n = 6;
10 8 M, n = 5;
10 7 M, n = 12;
10 6 M, n = 6.
|
|
PTH Increases NHE3 Phosphorylation--
We previously showed that
acute inhibition of cortical apical membrane NHE activity in rat kidney
by PTH is associated with increased NHE3 phosphorylation using an
indirect mobility shift assay. We now use OK cells to characterize
further the PTH-induced NHE3 phosphorylation. First, the time course of
increased NHE3 phosphorylation paralleled that of NHE3 inhibition with
detectable changes in NHE3 phosphorylation as early as 5 min after PTH
treatment (Fig. 2, A and
B). There is a trend toward lesser phosphorylation by 30 min, but total NHE3 phosphorylation is still greater than control.
Second, the increase in NHE3 phosphorylation was blocked by the PKA
inhibitor H89 (10 6 M) suggesting
involvement of PKA (Fig. 2, A and B). Third, the majority of phosphate content of NHE3 at base line as well as after PTH
was on serine residues (Fig. 2C) with phosphothreonine constituting less than 2% and phosphotyrosine less than 3% of the
counts. Fourth, PTH induced increase in NHE3 on multiple serine residues as evident by the increase in intensity of 7 tryptic phosphopeptides (phosphopeptides IV-X in Fig.
3, A and B).
Finally, the pattern of phosphorylation of NHE3 induced by
10 7 M PTH was identical to that
of 10 5 M 8-bromo-cAMP (Fig. 3,
B and C). Expression of a carboxyl-terminal cytoplasmic domain truncated c-Myc-tagged (amino acids 1-483) mutant
NHE3 produced a protein that was expressed at the cell surface
(biotin-accessible anti-c-Myc-reactive) but not phosphorylated at base
line or upon PTH addition (data not shown). These studies suggest that
PTH acutely leads to increased phosphorylation of multiple cytoplasmic
serines on NHE3 via the PKA pathway. In all of the above studies, total
cellular NHE3 phosphorylation was studied.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of PTH on NHE3 phosphorylation in OK
cells. A, representative experiment of NHE3
phosphorylation ± PKA inhibition. OK cells were pulsed with
32P, and native NHE3 was immunoprecipitated and resolved on
SDS-polyacrylamide gel electrophoresis, and NHE3 phosphorylation and
antigen were quantified by autoradiography and immunoblotting,
respectively. Cells were treated with PTH 10 7
M (20 min) with or without H89
(10 6 M). B, summary of
all experiments showing NHE3 phosphorylation signal normalized to NHE3
antigen signal. Bars depict mean ± S.E.
Asterisk indicates significant difference from control
(p < 0.05, ANOVA). Control (n = number
of experiments), n = 9; PTH 5 min, n = 9; PTH 30 min, n = 9; H89, n = 3; H89 + 5 min PTH, n = 5; H89 + 30 min PTH, n = 4. C, phosphoamino acid analysis. In vivo
phosphorylation of NHE3 was performed as described above with either
PTH or vehicle. The 32P-labeled immunoprecipitated NHE3 was
hydrolyzed to single amino acids and resolved by two-dimensional
chromatography. Location of standard phosphoamino acids (PS,
phosphoserine; PT, phosphothreonine; PY,
phosphotyrosine) is indicated. Two experiments showed similar
results.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of PTH on tryptic phosphopeptide map
of NHE3. OK cells were pulsed with 32P and treated
with the appropriate agonist, and native NHE3 was immunoprecipitated,
digested by trypsin, and resolved in two dimensions.
32P-Labeled phosphopeptides were phosphorimaged and
identified by roman numerals (I-X). Conditions were as
follows: control (Con, A), PTH
10 7 M × 10 min (B),
and 8-Br-cAMP 10 4 M × 10 min
(C). Three sets of experiments showed similar results.
|
|
PTH Decreases Surface NHE3 Antigen by Increasing NHE3
Endocytosis--
Although increases in NHE3 phosphorylation were
evident after 5 min of PTH treatment, changes in cell surface NHE3
antigen defined as the biotin-accessible fraction of total cellular
NHE3 were not detectable until 30 min after PTH treatment (Fig.
4, A and B). Total
cellular NHE3 remained unchanged (Fig. 4A). To examine
whether the decrease in surface antigen was due to increased endocytosis, we used the avidin protection and TCEP resistance assays
to examine late and total endocytosis, respectively. Control experiments performed at 4 °C where endocytosis was arrested
revealed a background signal of approximately 10-20% that from cells
at 37 °C. This likely represents biotinylated surface proteins that were not completely cleaved by TCEP or saturated with avidin. This
background signal did not appear to be consistently altered by PTH
treatment. PTH increased both the avidin-protected and TCEP-protected
fractions (Fig. 5) indicating that the
PTH stimulates both early and late NHE3 endocytosis.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of PTH on surface NHE3 antigen.
OK cells were treated with 10 7 M
PTH for the indicated period. Surface proteins were biotinylated and
retrieved from solubilized cell lysate by streptavidin-affinity
precipitation, and NHE3 antigen was quantified by immunoblot. Total
cellular NHE3 was quantified by immunoprecipitating NHE3 from whole
cell lysates. A, typical blot. B, summary of all
experiments. Symbols and bars depict mean ± S.E. Asterisk indicates significant difference from control
(p < 0.05, ANOVA). Control (n = number
of experiments), n = 10; 5 min PTH, n = 8; 15 min PTH, n = 4; 30 min PTH, n = 12.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of PTH on NHE3 endocytosis. OK
cells were surface-biotinylated, warmed to 37 °C for 40 min in the
presence or absence of 10 7 M PTH
for endocytosis, and the remaining surface-accessible biotin was either
saturated with avidin or cleaved with TCEP (see text for details). The
freshly internalized biotin-bearing proteins were retrieved by
streptavidin-agarose precipitation, and NHE3 antigen was quantified by
immunoblot. Some cells were kept at 4 °C throughout the procedure to
arrest endocytosis, and the signal represents the degree of failure of
either complete cleavage by TCEP or saturation by avidin. Four
independent experiments showed identical results.
|
|
Dependence on Dynamin--
Endocytosis can proceed via multiple
pathways (61, 62). Two of these pathways, the caveolin-mediated and
clathrin-coated vesicle pathways, are dependent on the GTPase dynamin
(63). A GTP binding-deficient dominant negative mutant dynamin
(dynK44N) was transiently expressed to block endogenous
dynamin function. In all the studies examining NHE3, only cells with
~80% transfection efficiency were used. Although the
inhibition of NHE3 activity by PTH after 5 min was not blocked by
dynK44A, PTH inhibition after 30 min was mostly abolished
(Fig. 6A). A small but
statistically insignificant inhibition was noted. Transfection with
wild type dynWT had no effect on the PTH-induced inhibition
at either 5 or 30 min (Fig. 6A). Note that in the presence
of dynK44A, base-line NHE3 activity was more variable from
plate to plate (Fig. 6A). To rule out data scattering as a
cause of the lack of effect of 30 min of PTH on NHE3 activity in the
presence of dynK44A, we examined PTH inhibition on NHE3
activity in a paired fashion using each plate as its own control. Fig.
6B shows that dynK44A abrogated whereas
dynWT did not affect the inhibition of NHE3 activity by
PTH.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of the dominant negative dynamin
(dynK44A) on the PTH-induced inhibition of
NHE3 activity. OK cells were transfected with either wild
type (dynWT) or dynK44A. A, unpaired
measurements. The effect of either 5 or 30 min of
10 7 M PTH on NHE3 activity was
measured fluorimetrically (BCECF) as
Na+-dependent pHi recovery after an
acid load (nigericin). Bars depict mean ± S.E.
Asterisk indicates significant difference from control
(p < 0.05, ANOVA). Control + dynWT,
n = 4; PTH + dynWT, n = 6;
control + dynK44A, n = 12; PTH + dynK44A, n = 12 (n = number
of experiments). B, paired measurements. NHE3 activity was
measured fluorimetrically (BCECF) as
Na+-dependent pHi recovery after an
acid load (NH3/NH4+
pulse/withdrawal); PTH (10 7 M × 30 min) was then added, and NHE3 activity was measured again in the
same cells on the same coverslip. Individual paired data points are
connected. Symbols and bars depict mean ± S.E. Asterisk indicates significant difference from control
(p < 0.05, paired t test).
n = number of pairs. dynWT,
n = 4; dynK44A, n = 10.
|
|
Next, we correlated the functional data with antigenic data. We did
these studies two ways. First, we examined the effect of
dynWT or dynK44A on native opossum NHE3 using
conditions exactly as described above for the activity assay using only
transfections with ~80% efficiency. Fig.
7, A and B, showed
that dynK44Acompletely blocked the PTH-induced
decrease in surface NHE3, whereas dynWT had no effect.
Second, we co-transfected the dynWT or dynK44A
construct along with carboxyl-terminal c-Myc-tagged opossum NHE3 and
performed the surface biotinylation assay with anti-c-Myc antisera.
This assay selects out only the cells that were transfected. The data
were virtually identical to that presented in Fig. 7, A and
B, using native NHE3 as a read-out (data not shown).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of the dominant negative dynamin
(dynK44A) on the PTH-induced decrease of
surface NHE3 antigen. OK cells were transfected with either
wild type (dynWT) or dynK44A. Cells were
treated with either PTH (10 7 M,
40 min) or vehicle for 40 min. Surface proteins were biotinylated and
retrieved from solubilized cell lysate streptavidin affinity
precipitation, and NHE3 antigen was quantified by immunoblot.
A, typical experiment. B, summary of 7 experiments. Bars depict mean ± S.E.
Asterisk indicates significant difference from control
(p < 0.05, unpaired t test).
|
|
 |
DISCUSSION |
When parathyroidectomized rats received an acute infusion of PTH,
a biphasic response was seen when early (1-2 h) inhibition of NHE3
activity was accompanied by increased NHE3 phosphorylation and later
(>2 h) inhibition was associated with decreased apical membrane NHE3
antigen (26). More detailed definition of this dual response is
difficult in intact animals. In OK cells, a similar biphasic response
was observed with slightly different kinetics. The reasons for the
disparity is unclear but likely relates to differences between intact
animals where multiple factors can mediate and modulate the acute PTH
response and in cell culture where a pure PTH effect is seen. The
timing of agonist delivery and exposure may also differ as the PTH was
given intravenously in the whole animal, whereas cells were exposed
instantly to the desired concentration. Nonetheless, the biphasic
response of regulation is clearly present in OK cells and thus provides
a model for further study of the mechanism of the response.
Early inhibition of NHE3 activity by PTH is associated with increased
NHE3 phosphorylation on multiple serines on the cytoplasmic domain of
NHE3. Phosphorylation of multiple cytoplasmic serines on NHE3 has been
described with PKA activation in fibroblasts transfected with NHE3 (39,
40, 42, 45) or native NHE3 in OK cells (42), acute addition of
endothelin in OK cells (43), and PKC activation in transfected cells in
one study (44) but not in another study (41). The functional importance
of specific phosphoserines has previously been documented (38, 40, 42, 44). In both OK cells and in the intact animal treated with PTH,
changes in NHE3 phosphorylation and activity follow the same time
course. This finding further supports the importance of phosphorylation in NHE3 functional regulation. The kinases involved in the inhibition for NHE3 by PTH has been controversial with current data suggesting a
dual PKA/PKC pathway (29-36). In this study, NHE3 phosphorylation was
completely blocked by the PKA inhibitor H89 and NHE3 phosphorylation pattern from cells treated with PTH or 8-Br-cAMP were identical when
compared side-by-side. This strongly suggests that the PTH-induced phosphorylation of NHE3 is mediated by PKA. In the whole animal only
PKA-activating PTH peptides were competent in inducing NHE3 trafficking
(53). However, this does not rule out a contributory role for PKC since
PKC activation can alter NHE3 activity by mechanisms independent of
changes in NHE3 phosphorylation (41, 44). There was a trend toward
lesser total cellular NHE3 whole protein phosphorylation at 30 min but
the phospho content was still higher than control. We did not
specifically examine surface protein phosphorylation in this study. It
is possible that there may be some reversal of surface NHE3
phosphorylation at 30 min. The small but statistically insignificant
inhibition by PTH at 30 min when dynamin was inhibited is also
compatible with reversal of modification of surface NHE3.
Similar to the data from rat renal cortex, the immediate inhibition of
NHE3 in OK cells was not accompanied by changes in surface NHE3
antigen. The inability of dominant negative dynamin to block the early
inhibition further supports the notion that changes in NHE3 intrinsic
activity may mediate the immediate inhibition. Numerous examples in
either native membrane vesicles or reconstituted proteoliposomes where
there is no possible NHE3 trafficking have shown regulation of
transport activity (38, 64-71). Substrate kinetic analysis of the
effect of PTH on native NHE3 in OK cells and of cAMP on
NHE3-transfected fibroblasts has revealed changes in
KNa or KH of NHE3 (28,
72), a finding that is not compatible with changes in surface
NHE3 antigen. Several groups have shown changes in NHE3 activity that
are not accounted for by changes in surface NHE3 antigen in response to
PKA activation (38), PKC activation (48), and modification of the actin
cytoskeleton (55). All NHEs appear to have comparable turnover rates at
base line when expressed in fibroblasts (73). However, the mechanism by
which changes in turnover rate of NHE3 is effected is currently unclear. A number of NHE binding partners have been described such as
calcineurin-homologous protein and calmodulin for NHE1 (74-77),
calmodulin and a variety of Src homology 3-containing proteins for NHE2
(78, 79), and certain members of the Na+/H+
exchanger regulatory factor (NHERF) family of proteins, ezrin and
megalin for NHE3 (45, 70-72, 80, 83, 84). The current model proposed
by Yun, Donowitz, and Weinman and co-workers (72, 80, 82, 83) suggests
that although NHERF phosphorylation is not regulated by PKA, NHERF
functions to relay PKA to access its substrate NHE3. Currently there is
no evidence suggesting that NHERF binding to NHE3 per se
alters NHE3 activity. Biemesderfer and co-workers (84) have proposed
that association of NHE3 with megalin can be a mechanism of altering
NHE3 activity without changes in NHE3 protein abundance in the plasma membrane.
Data supporting regulation of NHE3 trafficking have been described in
the rat kidney with acute and chronic hypertension (49-52), acute PTH
infusion (26, 53), and chronic metabolic acidosis (85) in fibroblasts
transfected with NHE3 (46-48, 54, 55) and in OK cells exposed to acid
pH (86) or endothelin (81). We now show that OK cells incubated with
PTH for 30 min caused inhibition of NHE3 activity and decrease in
surface NHE3 antigen. Decrease in steady state surface NHE3 can be due
to decreased rate of exocytic insertion or increased rate of endocytic
retrieval. In this study, we provide biochemical evidence that PTH
stimulates endocytic retrieval of NHE3 from the plasma membrane. Some
caution is warranted regarding the interpretation of biochemical data of trafficking. The biotinylation was performed at 4 °C which should
arrest all trafficking events, although we cannot completely rule out a
small persistent recycling during the labeling which will render the
assay not purely indicative of endocytotic retrieval. Another unlikely
but theoretically conceivable scenario is that accessibility of
reagents such as NHS-SS-biotin, avidin, and TCEP to NHE3 may be
partially masked by neighboring proteins. We have not ruled out the
possibility that binding of NHE3 by a protein such as megalin may
"mimic" the biochemical data suggesting regulation of NHE3
trafficking. However, the fact that decreased apical membrane NHE3
antigen was detected in rats given PTH (26, 53) strongly supports the
trafficking model. In addition, the fact that the GTP binding-defective
dominant negative dynamin blocked the 30-min inhibition of NHE3
activity is congruent with endocytotic retrieval of NHE3 as a mechanism
of inhibition. The dependence on dynamin suggests that NHE3 is
endocytosed via either the caveolin pathway, clathrin-coated vesicle
pathway, or both (61, 62). Chow and co-workers (54) have previously
shown that a different dominant negative mutant dynamin
(dynS45N) blocks endocytosis of NHE3 and documented a
functional role for e-COP protein in NHE3 trafficking in fibroblasts.
Chow and co-workers (54) have co-purified NHE3 with clathrin light and heavy chains and AP-1 and AP-2 adaptins in liver and ileal villi. In
concert, the current body of data supports regulation of NHE3 trafficking by the clathrin-coated vesicles pathway. We have not ruled
decreased exocytosis and increased endocytosis as joint mechanisms
mediating decreased surface NHE3.
One quantitative aspect of the data is noteworthy. More than two-thirds
of the maximal inhibition of NHE3 activity by PTH is achieved by 15 min
(Fig. 1B) when no detectable decreased surface NHE3 protein
was evident. After 30 min, when the activation of NHE3 endocytosis
decreased surface NHE3 (Fig. 4B), a modest additional decrease in NHE3 activity occurred (Fig. 1B). Although the
activity and surface antigen data were not obtained in the same cells, a semi-quantitative analysis is presented in Table
I where an attempt is made to estimate
surface NHE3 activity normalized to surface NHE3 antigen. It is evident
that the decrease in NHE3 activity at 15 min is all due to decreased
intrinsic NHE3 transport activity. As indicated above, this may be
mediated by NHE3 phosphorylation, binding to regulatory proteins, or
both. At 30 min when surface NHE3 decreased, NHE3 activity per surface
protein appears to have partially recovered. We postulated two
hypothetical models that are consistent with the empiric observations
(Fig. 8). In model 1, only a fraction of
surface NHE3 undergoes phosphorylation and dramatic reduction in
transport via yet undefined mechanisms at 15 min. At 30 min, the
phosphorylated fraction undergoes endocytosis leaving the remaining
surface transporters running at about the same rate as under control
conditions. In model 2, phosphorylation increases in all surface NHE3
at 15 min resulting in decrease in NHE3 transport activity. A
restricted population of surface NHE3 then undergoes endocytosis. The
surface transporters that do not get internalized partially recover
their function via reversal of phosphorylation, binding to cofactors,
or both. In both models, total cellular NHE3 phosphorylation remains
elevated at 30 min due mainly to the intracellular endocytosed pool of
NHE3. The ability of dynK44A to block completely inhibition
of NHE3 at 30 min does suggest a time-dependent reversal of
surface NHE3, although a caveat of this interpretation is that
dynK44A may theoretically interfere with the inhibition of
NHE3 surface protein. Both models proposed remain conjectural at
present. They are by no means proven, but they are compatible with the
existing data.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 8.
Two hypothetical models consistent with the
experimental observations. Approximate relative NHE3 activities
and surface NHE3 antigens are shown for 0, 15, and 30 min after PTH
addition.
|
|
In summary, the data from rat renal cortex (43) and from OK cells
suggest a model of biphasic acute regulation of NHE3 activity by PTH
involving dual mechanisms. Immediate inhibition is effected by changes
in intrinsic activity of NHE3 and associated with phosphorylation. The
above two models are purely conjectural at the moment, but they are
consistent with the experimental findings of multiple serines on the
cytoplasmic membrane via PKA. More sustained inhibition is mediated by
endocytic retrieval of NHE3 from the plasma membrane via a
dynamin-dependent pathway. Presently, the fates of the
remaining surface transporters and the ones that have undergone
endocytosis are unknown.
 |
ACKNOWLEDGEMENTS |
We acknowledge the technical expertise of
Ladonna A. Crowder. We are grateful to Dr. Michel Baum and Dr.
Robert Alpern for their helpful discussions and Dr. Sandy Schmid for
providing us with reagents.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants DK-48482 and DK-54396, the Department of Veterans Affairs
Research Service, the American Heart Association Texas Affiliate Grant
98G-052, and the National Kidney Foundation of Texas.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of National Institutes of Health Training Grant T32
DK07257-17.
§
To whom correspondence should be addressed: Dept. Of Internal
Medicine, University of Texas Southwestern Medical Center, 5323 Harry
Hines Blvd., Dallas, TX 75235-8856. Tel.: 214-648-3152; Fax:
214-648-2071; E-mail: orson.moe@vtsouthwestern.edu.
Published, JBC Papers in Press, June 23, 2000, DOI 10.1074/jbc.M000600200
 |
ABBREVIATIONS |
The abbreviations used are:
PTH, parathyroid
hormone;
OK, opossum kidney;
PKA, cAMP-dependent protein
kinase;
PKC, protein kinase C;
Mes, 4-morpholineethanesulfonic acid;
TCEP, Tris(2-carboxyethyl)phosphine hydrochloride;
PBS, phosphate-buffered saline;
dyn, dynamin;
WT, wild type;
ANOVA, analysis
of variance;
NHERF, Na+/H+ exchanger regulatory
factor;
BCECF, 2',7'-bis(2-carboxyethyl)-
5(6)-carboxyfluorescein.
 |
REFERENCES |
| 1.
|
Seldin, D. W.
(1999)
Nephron
81, Suppl. 1,
2-7
|
| 2.
|
Bourdeau, J. E.
(1993)
Semin. Nephrol.
13,
191-201
|
| 3.
|
Bindels, R. J.
(1993)
J. Exp. Biol
184,
89-104
|
| 4.
|
Suki, W. N.
(1979)
Am. J. Physiol.
237,
F1-F6
|
| 5.
|
Puschett, J. B.,
Zurbach, P.,
and Sylk, D.
(1976)
Kidney Int.
9,
501-510
|
| 6.
|
Bank, N.,
and Aynedian, H. S.
(1976)
J. Clin. Invest.
58,
336-344
|
| 7.
|
Iino, Y.,
and Burg, M. B.
(1979)
Am. J. Physiol.
236,
F387-F391
|
| 8.
|
McKinney, T. D.,
and Myers, P.
(1980)
Am. J. Physiol.
239,
F127-F134
|
| 9.
|
McKinney, T. D.,
and Myers, P.
(1980)
Am. J. Physiol.
238,
F166-F179
|
| 10.
|
Liu, F.-Y.,
and Cogan, M. G.
(1989)
J. Clin. Invest.
84,
83-91
|
| 11.
|
Agus, Z. S.,
Gardner, L. B.,
Beck, L. H.,
and Goldberg, M.
(1973)
Am. J. Physiol.
224,
1143-1148
|
| 12.
|
Sutton, R. A.,
Wong, N. L. M.,
and Dirks, J. H.
(1979)
Kidney Int.
15,
520-533
|
| 13.
|
Marone, C. C.,
Wong, N. L.,
Sutton, R. A.,
and Dirks, J. H.
(1983)
J. Lab. Clin. Med.
101,
264-273
|
| 14.
|
Mori, Y.,
Machida, T.,
Miyakawa, S.,
and Bomsztyk, K.
(1992)
Pharmacol. Toxicol.
70,
201-204
|
| 15.
|
Priesig, P. A.,
Ives, H. E.,
Cragoe, E. J., Jr.,
Alpern, R. J.,
and Rector, F. C., Jr.
(1987)
J. Clin. Invest.
80,
970-978
|
| 16.
|
Biemesderfer, D.,
Pizzonia, J.,
Abu-Alfa, A.,
Exner, M.,
Reilly, R.,
Igarashi, P.,
and Aronson, P. S.
(1993)
Am. J. Physiol.
265,
F736-F742
|
| 17.
|
Amemiya, M.,
Loffing, J.,
Lötscher, M.,
Kaissling, B.,
Alpern, R. J.,
and Moe, O. W.
(1995)
Kidney Int.
48,
1206-1215
|
| 18.
|
Biemesderfer, D.,
Rutherford, P. A.,
Nagy, T.,
Pizzonia, J. H.,
Abu-Alfa, A. K.,
and Aronson, P. S.
(1997)
Am. J. Physiol.
273,
F289-F299
|
| 19.
|
Yun, C. C. H.,
Tse, C.-M.,
Nath, S. K.,
Levine, S. A.,
Brant, S. R.,
and Donowitz, M.
(1995)
Am. J. Physiol.
269,
G1-G11
|
| 20.
|
Wakabayashi, S.,
Shigekawa, M.,
and Pouyssègur, J.
(1997)
Physiol. Rev.
77,
51-74
|
| 21.
|
Orlowski, J.,
and Grinstein, S.
(1997)
J. Biol. Chem.
272,
22373-22376
|
| 22.
|
Gesek, F. A.,
and Schoolwerth, A. C.
(1990)
Am. J. Physiol.
258,
F514-F521
|
| 23.
|
Sasaki, S.,
and Marumo, F.
(1991)
Am. J. Physiol.
260,
F833-F838
|
| 24.
|
Pastoriza-Munoz, E.,
Harrington, R. M.,
and Graber, M. L.
(1992)
J. Clin. Invest.
89,
1485-1495
|
| 25.
|
Kahn, A. M.,
Dolson, G. M.,
Hise, M. K.,
Bennet, S. C.,
and Weinman, E. J.
(1985)
Am. J. Physiol.
248,
F212-F218
|
| 26.
|
Fan, L.,
Wiederkehr, M. R.,
Collazo, R.,
Huang, H.,
Crowder, L. A.,
and Moe, O. W.
(1999)
J. Biol. Chem.
274,
11289-11295
|
| 27.
|
Pollock, A. S.,
Warnock, D. G.,
and Strewler, G. J.
(1986)
Am. J. Physiol.
250,
F217-F225
|
| 28.
|
Miller, R. T.,
and Pollock, A. S.
(1987)
J. Biol. Chem.
262,
9115-9120
|
| 29.
|
Moran, A.,
Montrose, M. H.,
and Murer, H.
(1988)
Biochim. Biophys. Acta
969,
48-56
|
| 30.
|
Helmle-Kolb, C.,
Montrose, M. H.,
and Murer, H.
(1990)
Pfluegers Arch.
416,
615-623
|
| 31.
|
Helmle-Kolb, C.,
Montrose, M. H.,
Stange, G.,
and Murer, H.
(1990)
Pfluegers Arch.
415,
461-470
|
| 32.
|
Reshkin, S. J.,
Forgo, J.,
and Murer, H.
(1991)
J. Membr. Biol.
124,
227-237
|
| 33.
|
Mrkic, B.,
Forgo, J.,
Murer, H.,
and Helmle-Kolb, C.
(1992)
J. Membr. Biol.
130,
205-217
|
| 34.
|
Mrkic, B.,
Tse, C.-M.,
Forgo, J.,
Helmle-Kolb, C.,
Donowitz, M.,
and Murer, H.
(1993)
Pfluegers Arch.
424,
377-384
|
| 35.
|
Azarani, A.,
Goltzman, D.,
and Orlowski, J.
(1995)
J. Biol. Chem.
270,
20004-20010
|
| 36.
|
Azarani, A.,
Goltzman, D.,
and Orlowski, J.
(1996)
J. Biol. Chem.
271,
14931-14936
|
| 37.
|
Moe, O. W.
(1997)
Curr. Opin. Nephrol. Hypertens
6,
440-446
|
| 38.
|
Moe, O. W.
(1999)
J. Am. Soc. Nephrol.
10,
2412-2425
|
| 39.
|
Moe, O. W.,
Amemiya, M.,
and Yamaji, Y.
(1995)
J. Clin. Invest.
96,
2187-2194
|
| 40.
|
Kurashima, K., Yu, F. H.,
Cabado, A. G.,
Szabó, E. Z.,
Grinstein, S.,
and Orlowski, J.
(1997)
J. Biol. Chem.
272,
28672-28679
|
| 41.
|
Yip, J. W.,
Ko, W. H.,
Viberti, G.,
Huganir, R. L.,
Donowitz, M.,
and Tse, C. M.
(1997)
J. Biol. Chem.
272,
18473-18480
|
| 42.
|
Zhao, H.,
Wiederkehr, M. R.,
Collazo, R.,
Fan, L.,
Crowder, L. A.,
and Moe, O. W.
(1999)
J. Biol. Chem.
274,
3978-3987
|
| 43.
|
Peng, Y.,
Moe, O. W.,
Chu, T.-S.,
Preisig, P. A.,
Yanagisawa, M.,
and Alpern, R. J.
(1999)
Am. J. Physiol.
276,
C938-C945
|
| 44.
|
Wiederkehr, M. R.,
Zhao, H.,
and Moe, O. W.
(1999)
Am. J. Physiol.
276,
C1205-C1217
|
| 45.
|
Zizak, M.,
Lamprecht, G.,
Steplock, D.,
Tariq, N.,
Shenolikar, S.,
Donowitz, M.,
Yun, C. H.,
and Weinman, E. J.
(1999)
J. Biol. Chem.
274,
24753-23758
|
| 46.
|
D'Souza, S.,
Garcia-Cabado, A., Yu, F.,
Teter, K.,
Lukacs, G.,
Skorecki, K.,
Moore, H. P.,
Orlowski, J.,
and Grinstein, S.
(1998)
J. Biol. Chem.
273,
2035-2043
|
| 47.
|
Kurashima, K.,
Szabo, E. Z.,
Lukacs, G.,
Orlowski, J.,
and Grinstein, S.
(1998)
J. Biol. Chem.
273,
20828-20836
|
| 48.
|
Janecki, A. J.,
Montrose, M. H.,
Zimniak, P.,
Zweibaum, A.,
Tse, C. M.,
Khurana, S.,
and Donowitz, M.
(1998)
J. Biol. Chem.
273,
8790-7898
|
| 49.
|
Zhang, Y.,
Mircheff, A. K.,
Hensley, C. B.,
Magyar, C. E.,
Warnock, D. G.,
Chambrey, R.,
Yip, K. P.,
Marsh, D. J.,
Holstein-Rathlou, N. H.,
and McDonough, A. A.
(1996)
Am. J. Physiol.
270,
F1004-F1014
|
| 50.
|
Zhang, Y. B.,
Magyar, C. E.,
Holstein-Rathlou, N.-H.,
and McDonough, A. A.
(1998)
J. Am. Soc. Nephrol.
9,
531-537
|
| 51.
|
Zhang, Y.,
Magyar, C. E.,
Norian, J. M.,
Holstein-Rathlou, N. H.,
Mircheff, A. K.,
and McDonough, A. A.
(1998)
Am. J. Physiol.
274,
C1090-C1100
|
| 52.
|
Yip, K, P.,
Tse, C, M.,
McDonough, A, A,
and Marsh, D. J.
(1998)
Am. J. Physiol.
275,
F565-F575
|
| 53.
|
Zhang, Y.,
Norian, J. M.,
Magyar, C. E.,
Holstein-Rathlou, N. H.,
Mircheff, A. K.,
and McDonough, A. A.
(1999)
Am. J. Physiol.
276,
F711-F719
|
| 54.
|
Chow, C.-W.,
Khurana, S.,
Woodside, M.,
Grinstein, S.,
and Orlowski, J.
(1999)
J. Biol. Chem.
274,
37551-37558
|
| 55.
|
Kurashima, K.,
D'Souza, S.,
Szászi, K.,
Ramjeessingh, R.,
Orlowski, J.,
and Grinstein, S.
(1999)
J. Biol. Chem.
274,
29843-29849
|
| 56.
|
Altschuler, Y.,
Barbas, S. M.,
Terlecky, L. J.,
Tang, K.,
Hardy, S.,
Mostov, K. E.,
and Schmid, S. L.
(1998)
J. Cell Biol.
143,
1871-1881
|
| 57.
|
Moe, O. W.,
Miller, R. T.,
Horie, S.,
Cano, A.,
Priesig, P. A.,
and Alpern, R. J.
(1991)
J. Clin. Invest.
88,
1703-1708
|
| 58.
|
Horie, S.,
Moe, O. W.,
Tejedor, A.,
and Alpern, R. J.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4742-4745
|
| 59.
|
Gottardi, C. J.,
Dunbar, L. A.,
and Capan, M. J.
(1995)
Am. J. Physiol.
268,
F285-F295
|
| 60.
|
Carter, L. L.,
Redelmeier, T. E.,
Woollenweber, L. A.,
and Schmid, S. L.
(1993)
J. Cell Biol.
120,
37-40
|
| 61.
|
Schmid, S. L.,
and Damke, H.
(1995)
FASEB J.
9,
1445-1453
|
| 62.
|
Lamaze, C.,
and Schmid, S. L.
(1995)
Curr. Opin. Cell Biol.
7,
573-580
|
| 63.
|
Schmid, S. L.,
McNiven, M. A.,
and De Camilli, P.
(1998)
Curr. Opin. Cell Biol.
4,
504-512
|
| 64.
|
Weinman, E. J.,
and Shenolikar, S.
(1986)
J. Membr. Biol.
93,
133-139
|
| 65.
|
Weinman, E. J.,
Shenolikar, S.,
and Kahn, A. M.
(1987)
Am. J. Physiol.
352,
F19-F25
|
| 66.
|
Talor, Z.,
and Mejicano, G. C.
(1988)
Res. Commun. Chem. Pathol. Pharmacol.
61,
335-343
|
| 67.
|
Weinman, E. J.,
Dubinsky, W. P.,
Dinh, Q.,
Steplock, D.,
and Shenolikar, S.
(1989)
J. Membr. Biol.
109,
233-241
|
| 68.
|
Weinman, E. J.,
Dubinsky, W. P.,
and Shenolikar, S.
(1988)
J. Membr. Biol.
101,
11-18
|
| 69.
|
Weinman, E. J.,
Steplock, D.,
Bui, G.,
Yuan, N.,
and Shenolikar, S.
(1990)
Am. J. Physiol.
258,
F1254-F1258
|
| 70.
|
Weinman, E. J.,
Steplock, D.,
and Shenolikar, S.
(1993)
J. Clin. Invest.
92,
1781-1786
|
| 71.
|
Weinman, E. J.,
Steplock, D.,
Wang, Y.,
and Shenolikar.
(1995)
J. Clin. Invest.
95,
2143-2149
|
| 72.
|
Lamprecht, G.,
Weinman, E. J.,
and Yun, C. H. C.
(1998)
J. Biol. Chem.
273,
29972-29978
|
| 73.
|
Cavet, M. E.,
Akhter, S.,
de Medina, F. S.,
Donowitz, M.,
and Tse, C.-M.
(1999)
Am. J. Physiol.
277,
C1111-C1121
|
| 74.
|
Lin, X.,
and Barber, D. L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12631-12636
|
| 75.
|
Bertrand, B.,
Wakabayashi, S.,
Ikeda, T.,
Pouyssegur, J.,
and Shigakawa, M.
(1994)
J. Biol. Chem.
269,
13703-13709
|
| 76.
|
Wakabayashi, S.,
Bertrand, B.,
Ikeda, T.,
Pouyssegur, J.,
and Shigekaea, M.
(1994)
J. Biol. Chem.
269,
13710-13715
|
| 77.
|
Wakabayashi, S.,
Ikeda, T.,
Noel, J.,
Schmitt, B.,
Orlowski, J.,
Pouyssegur, J.,
and Shigekawa, M.
(1995)
J. Biol. Chem.
270,
26460-26465
|
| 78.
|
Nath, S. K.,
Kambadur, R.,
Yun, C. H.,
Donowitz, M.,
and Tse, C. M.
(1999)
Am. J. Physiol.
276,
C873-C882
|
| 79.
|
Chow, C. W.,
Woodside, M.,
Demaurex, N., Yu, F. H.,
Plant, P.,
Rotin, D.,
Grinstein, S.,
and Orlowski, J.
(1999)
J. Biol. Chem.
274,
10481-10488
|
| 80.
|
Yun, C. H. C.,
Oh, S.,
Zizak, M.,
Steplock, D.,
Tsao, S.,
Tse, C.-M.,
Weinman, E. J.,
and Donowitz, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3010-3015
|
| 81.
|
Peng, Y.,
Amemiya, M.,
Yang, X.,
Moe, O. W.,
Priesig, P. A.,
Yanagisawa, M.,
and Alpern, R. J.
(1999)
J. Am. Soc. Nephrol.
10,
459 (abstr.)
|
| 82.
|
Yun, C. H. C.,
Lamprecht, G.,
Forster, D. V.,
and Sidor, A.
(1998)
J. Biol. Chem.
273,
25856-25863
|
| 83.
|
Minkoff, C.,
Shenolikar, S.,
and Weinman, E. J.
(1999)
Curr. Opin. Nephrol. Hypertens
5,
603-608
|
| 84.
|
Biemesderfer, D.,
Nagy, T.,
DeGray, B.,
and Aronson, P. S.
(1999)
J. Biol. Chem.
274,
17518-17524
|
| 85.
|
Biemesderfer, D.,
Wang, T.,
DeGray, B.,
and Aronson, P. S.
(1997)
J. Am. Soc. Nephrol.
8,
3 (abstr.)
|
| 86.
|
Yang, X.,
Peng, Y.,
Amemiya, M.,
Moe, O. W.,
Priesig, P. A.,
and Alpern, R. J.
(1999)
J. Am. Soc. Nephrol.
10,
12 (abstr.)
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. T. Alexander and S. Grinstein
Tethering, recycling and activation of the epithelial sodium-proton exchanger, NHE3
J. Exp. Biol.,
June 1, 2009;
212(11):
1630 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. He, H. Zhang, and C. C. Yun
IRBIT, Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3, Binds Na+/H+ Exchanger NHE3 and Activates NHE3 Activity in Response to Calcium
J. Biol. Chem.,
November 28, 2008;
283(48):
33544 - 33553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. A. Bezerra, A. C. C. Girardi, L. R. Carraro-Lacroix, and N. A. Reboucas
Mechanisms underlying the long-term regulation of NHE3 by parathyroid hormone
Am J Physiol Renal Physiol,
May 1, 2008;
294(5):
F1232 - F1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Muller, P. Houpert, J. Cambar, and M.-H. Henge-Napoli
Role of the Sodium-Dependent Phosphate Cotransporters and Absorptive Endocytosis in the Uptake of Low Concentrations of Uranium and Its Toxicity at Higher Concentrations in LLC-PK1 Cells
Toxicol. Sci.,
February 1, 2008;
101(2):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cai, L. Wu, W. Qu, D. Malhotra, Z. Xie, J. I. Shapiro, and J. Liu
Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex
Am J Physiol Cell Physiol,
February 1, 2008;
294(2):
C555 - C563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, H.-C. Huang, H. Yin, R. J. Alpern, and P. A. Preisig
RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3
Am J Physiol Renal Physiol,
October 1, 2007;
293(4):
F1054 - F1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Donowitz and X. Li
Regulatory Binding Partners and Complexes of NHE3
Physiol Rev,
July 1, 2007;
87(3):
825 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Kocinsky, D. W. Dynia, T. Wang, and P. S. Aronson
NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F212 - F218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, H. J. Lee, D. S. Cooper, L. Cebotaro, P. D. Walden, I. Choi, and C. C. Yun
Coexpression of MAST205 inhibits the activity of Na+/H+ exchanger NHE3
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F428 - F437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Honegger, P. Capuano, C. Winter, D. Bacic, G. Stange, C. A. Wagner, J. Biber, H. Murer, and N. Hernando
Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein directly activated by cAMP (EPAC)
PNAS,
January 17, 2006;
103(3):
803 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, H. Sun, F. Lang, and C. C. Yun
Activation of NHE3 by dexamethasone requires phosphorylation of NHE3 at Ser663 by SGK1
Am J Physiol Cell Physiol,
October 1, 2005;
289(4):
C802 - C810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Bobulescu, V. Dwarakanath, L. Zou, J. Zhang, M. Baum, and O. W. Moe
Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis
Am J Physiol Renal Physiol,
October 1, 2005;
289(4):
F685 - F691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Kocinsky, A. C. C. Girardi, D. Biemesderfer, T. Nguyen, S. Mentone, J. Orlowski, and P. S. Aronson
Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites
Am J Physiol Renal Physiol,
August 1, 2005;
289(2):
F249 - F258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shimada, M. J. Mahon, P. A. Greer, and G. V. Segre
The Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide Is Hydrolyzed and Its Signaling Properties Are Altered by Directly Binding the Calpain Small Subunit
Endocrinology,
May 1, 2005;
146(5):
2336 - 2344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. C. Girardi, F. Knauf, H.-U. Demuth, and P. S. Aronson
Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells
Am J Physiol Cell Physiol,
November 1, 2004;
287(5):
C1238 - C1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Yang, A. B. Maunsbach, P. K. K. Leong, and A. A. McDonough
Differential traffic of proximal tubule Na+ transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes
Am J Physiol Renal Physiol,
November 1, 2004;
287(5):
F896 - F906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. K. Leong, L. E. Yang, H. W. Lin, N. H. Holstein-Rathlou, and A. A. McDonough
Acute hypotension induced by aortic clamp vs. PTH provokes distinct proximal tubule Na+ transporter redistribution patterns
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2004;
287(4):
R878 - R885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fuster, O. W. Moe, and D. W. Hilgemann
Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods
PNAS,
July 13, 2004;
101(28):
10482 - 10487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hayashi, K. Szaszi, N. Coady-Osberg, W. Furuya, A. P. Bretscher, J. Orlowski, and S. Grinstein
Inhibition and Redistribution of NHE3, the Apical Na+/H+ Exchanger, by Clostridium difficile Toxin B
J. Gen. Physiol.,
April 26, 2004;
123(5):
491 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Di Sole, R. Cerull, V. Babich, H. Quinones, S. M. Gisler, J. Biber, H. Murer, G. Burckhardt, C. Helmle-Kolb, and O. W. Moe
Acute Regulation of Na/H Exchanger NHE3 by Adenosine A1 Receptors Is Mediated by Calcineurin Homologous Protein
J. Biol. Chem.,
January 23, 2004;
279(4):
2962 - 2974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Klisic, J. Zhang, V. Nief, L. Reyes, O. W. Moe, and P. M. Ambuhl
Albumin Regulates the Na+/H+ Exchanger 3 in OKP Cells
J. Am. Soc. Nephrol.,
December 1, 2003;
14(12):
3008 - 3016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Lederer, S. J. Khundmiri, and E. J. Weinman
Role of NHERF-1 in Regulation of the Activity of Na-K ATPase and Sodium-Phosphate Co-transport in Epithelial Cells
J. Am. Soc. Nephrol.,
July 1, 2003;
14(7):
1711 - 1719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Levi
Role of PDZ Domain-Containing Proteins and ERM Proteins in Regulation of Renal Function and Dysfunction
J. Am. Soc. Nephrol.,
July 1, 2003;
14(7):
1949 - 1951.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Gross, O Fedotoff, A Pushkin, N Abuladze, D Newman, and I Kurtz
Phosphorylation-induced modulation of pNBC1 function: distinct roles for the amino- and carboxy-termini
J. Physiol.,
June 15, 2003;
549(3):
673 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Laverty, C. McWilliams, A. Sheldon, and S. S. Arnason
PTH stimulates a Cl--dependent and EIPA-sensitive current in chick proximal tubule cells in culture
Am J Physiol Renal Physiol,
May 1, 2003;
284(5):
F987 - F995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Tenenhouse and H. Murer
Disorders of Renal Tubular Phosphate Transport
J. Am. Soc. Nephrol.,
January 1, 2003;
14(1):
240 - 247.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Besse-Eschmann, J. Klisic, V. Nief, M. Le Hir, B. Kaissling, and P. M. Ambuhl
Regulation of the Proximal Tubular Sodium/Proton Exchanger NHE3 in Rats with Puromycin Aminonucleoside (PAN)-Induced Nephrotic Syndrome
J. Am. Soc. Nephrol.,
September 1, 2002;
13(9):
2199 - 2206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Akhter, O. Kovbasnjuk, X. Li, M. Cavet, J. Noel, M. Arpin, A. L. Hubbard, and M. Donowitz
Na+/H+ exchanger 3 is in large complexes in the center of the apical surface of proximal tubule-derived OK cells
Am J Physiol Cell Physiol,
September 1, 2002;
283(3):
C927 - C940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Klisic, M. C. Hu, V. Nief, L. Reyes, D. Fuster, O. W. Moe, and P. M. Ambuhl
Insulin activates Na+/H+ exchanger 3: biphasic response and glucocorticoid dependence
Am J Physiol Renal Physiol,
September 1, 2002;
283(3):
F532 - F539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Di Sole, R. Cerull, V. Casavola, O. W Moe, G. Burckhardt, and C. Helmle-Kolb
Molecular aspects of acute inhibition of Na+-H+ exchanger NHE3 by A2-adenosine receptor agonists
J. Physiol.,
June 1, 2002;
541(2):
529 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sterling, D.-H. Lin, R.-M. Gu, K. Dong, S. C. Hebert, and W.-H. Wang
Inhibition of Protein-tyrosine Phosphatase Stimulates the Dynamin-dependent Endocytosis of ROMK1
J. Biol. Chem.,
February 1, 2002;
277(6):
4317 - 4323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Gross, K Hawkins, A Pushkin, P Sassani, R Dukkipati, N Abuladze, U Hopfer, and I Kurtz
Phosphorylation of Ser982 in the sodium bicarbonate cotransporter kNBC1 shifts the HCO3-: Na+ stoichiometry from 3:1 to 2:1 in murine proximal tubule cells
J. Physiol.,
December 15, 2001;
537(3):
659 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Cavet, S. Akhter, R. Murtazina, F. Sanchez de Medina, C.-M. Tse, and M. Donowitz
Half-lives of plasma membrane Na+/H+ exchangers NHE1-3: plasma membrane NHE2 has a rapid rate of degradation
Am J Physiol Cell Physiol,
December 1, 2001;
281(6):
C2039 - C2048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Weinman, C. M. Evangelista, D. Steplock, M.-Z. Liu, S. Shenolikar, and A. Bernardo
Essential Role for NHERF in cAMP-mediated Inhibition of the Na+-HCO3- Co-transporter in BSC-1 Cells
J. Biol. Chem.,
November 2, 2001;
276(45):
42339 - 42346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, J. F. Collins, L. Bai, P. R. Kiela, R. M. Lynch, and F. K. Ghishan
Epidermal growth factor regulation of rat NHE2 gene expression
Am J Physiol Cell Physiol,
August 1, 2001;
281(2):
C504 - C513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Biemesderfer, B. DeGray, and P. S. Aronson
Active (9.6 S) and Inactive (21 S) Oligomers of NHE3 in Microdomains of the Renal Brush Border
J. Biol. Chem.,
March 23, 2001;
276(13):
10161 - 10167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Hu, L. Fan, L. A. Crowder, Z. Karim-Jimenez, H. Murer, and O. W. Moe
Dopamine Acutely Stimulates Na+/H+ Exchanger (NHE3) Endocytosis via Clathrin-coated Vesicles. DEPENDENCE ON PROTEIN KINASE A-MEDIATED NHE3 PHOSPHORYLATION
J. Biol. Chem.,
July 13, 2001;
276(29):
26906 - 26915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Szaszi, K. Kurashima, K. Kaibuchi, S. Grinstein, and J. Orlowski
Role of the Cytoskeleton in Mediating cAMP-dependent Protein Kinase Inhibition of the Epithelial Na+/H+ Exchanger NHE3
J. Biol. Chem.,
October 26, 2001;
276(44):
40761 - 40768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gross, K. Hawkins, A. Pushkin, P. Sassani, R. Dukkipati, N. Abuladze, U. Hopfer, and I. Kurtz
Phosphorylation of Ser982 in the sodium bicarbonate cotransporter kNBC1 shifts the HCO3- : Na+ stoichiometry from 3 : 1 to 2 : 1 in murine proximal tubule cells
J. Physiol.,
November 21, 2001;
(2001)
200101295.
[Abstract]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|